Abstract: Primary liver cancer is a common malignant tumor. In China, the fatality rate of primary liver cancer
ranks the third among cancers. Chronic liver diseases such as HBV/HCV infection and cirrhosis are important
risk factors for primary liver cancer, which affect the development and prognosis. Currently, surgical treatments
such as liver resection and liver transplantation, local treatments such as local ablation and hepatic artery
interventional therapy, and systemic treatments such as molecular targeted therapy and chemotherapy greatly
improve the survival rate of patients with primary liver cancer. However, all these treatments have certain
limitations. In addition to the treatments for primary liver cancer, the treatment for basic liver disease is also
very important, whether for reducing the occurrence of primary liver cancer or for controlling the recurrence
after surgery. As for the treatment of basic liver diseases, the first thing to do is to control the causes. For
example, patients with virus infection should be treated with antiviral therapy. A long-term treatment to control
the inflammation and fibrosis is also needed. Plenty of studies have shown that traditional Chinese medicine
has a unique advantage in liver protection, anti-inflammatory and anti-fibrosis. Traditional Chinese medicine
plays an effective role in the treatment of basic liver disease in patients with primary liver cancer.